Toremifene Citrate (CAS 89778-27-8) API Manufacturer & Supplier in India

Toremifene Citrate is a high-purity Selective Estrogen Receptor Modulator (SERM) supplied by Mediocon Inc as an Active Pharmaceutical Ingredient (API) conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India, it meets the stringent quality requirements of global pharmaceutical manufacturers.

Toremifene Citrate is the citrate salt form of Toremifene, offering enhanced bioavailability and formulation stability for the treatment of hormone-sensitive breast cancer in postmenopausal women.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Breast cancer (estrogen receptor-positive)
• Post-menopausal hormonal therapy
• SERM-based oncology formulations
• Hormonal receptor modulation research

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings